Toshiba Is Under A Tight Deadline To Sell Division

Japan’s Toshiba Corp faces a Friday deadline to win Chinese antitrust approval to sell its prized $18 billion memory-chip business by end-March, raising the possibility the deadline may be missed and that it will seek alternatives such as an IPO.

The conglomerate agreed last year to sell the world’s second-biggest producer of NAND flash memory chips to a consortium led by U.S. private equity firm Bain Capital to plug a huge financial hole left by the bankruptcy of its U.S. nuclear unit.

The company has been aiming to complete the sale by March 31, the end of its business year. It said in September that it would need approval from antimonopoly authorities by March 23 to meet that deadline.

Read the full article here

Follow us on social media for the latest updates in B2B!

Image

Latest

TheAIAudit
Introducing TheAIAudit: A Platform Built to Measure, Monitor, and Govern Enterprise AI
May 22, 2026

Enterprise AI is advancing faster than most companies can govern it. Behind the scenes, AI systems are already influencing decisions tied to revenue, operations, compliance, customer outcomes, and risk — yet many organizations still lack a clear way to measure, explain, or oversee what those systems are doing. That is the gap TheAIAudit was…

Read More
Leadership
How the Future of Work Is Being Reshaped by AI, Human Creativity, and Customer-Centered Leadership
May 21, 2026

As artificial intelligence rapidly reshapes industries, many professionals are asking the same urgent question: what happens when AI starts replacing not just repetitive tasks, but the foundational entry-level roles that once launched careers? According to Goldman Sachs Research, AI could expose the equivalent of 300 million jobs globally to automation, while potentially automating tasks…

Read More
finance
Dr. Silver Kung’s Path From $10 Million in Debt to a Multibillion-Dollar Finance Career
May 21, 2026

Global finance is being tested by forces that no balance sheet can fully predict: unstable supply chains, geopolitical shocks, tighter credit conditions and the accelerating rise of AI. In trade finance especially, success depends on more than capital; it requires judgment, discipline and the ability to see risk before it becomes disruption. As automation…

Read More
specialty pharmacy
At the Center of Care: How Specialty Pharmacy Aligns Patients, Providers, and Payers
May 21, 2026

As healthcare costs continue to rise, more patients are finding themselves navigating not just illness, but the growing complexity of paying for treatment. Specialty pharmacy sits right at the center of that challenge—often out of sight, but increasingly essential to how modern care actually works. These high-cost, high-touch therapies now make up more than…

Read More